Camlin Fine Sciences Ltd Financials
Company Logo

Camlin Fine Sciences Ltd Financial Statement

Camlin Fine Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue229.99
Operating Expense309.17
Net Profit-72.62
Net Profit Margin-31.58
Earning Per Share-4.34
EBIDTA-35.82
Effective Tax Rate-6.87
Invest in Camlin Fine Sciences Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Camlin Fine Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual773.26
Operating Expenses Annual746.13
Operating Profit Annual44.08
Interest Annual54.33
Depreciation46.77
Net Profit Annual-51.39
Tax Annual-8.24

Camlin Fine Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning4.35
Cash Flow from Operations82.10
Cash Flow from Investing-51.72
Cash Flow from Financing-34.05
Cash Flow at the End0.68

Camlin Fine Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)6.67
PBIT Margin (%)0.29
PBT Margin (%)0.28
Net PROFIT Margin (%)-6.65
Return On Networth / Equity (%)-7.57
Return On Networth /Employed (%)0.18
Return On Assets (%)-4.12
Total Debt / Equity (X)0.83
Asset Turnover Ratio (%)0.62

Camlin Fine Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual576.70
Total Current Assets Annual860.50
Non Current Assets Annual711.49
Total Shareholders Funds Annual715.71
Total Assets Annual1,571.99

Camlin Fine Sciences Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-5.98

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2023

EPS beaten by 0.00%

Get Your FAQs Right

As of Nov 23, 2024, Camlin Fine Sciences Ltd has a market capitalization of 1,494.63 Cr. Value Research classifies it as a Small-Cap company.
No, Camlin Fine Sciences Ltd is not debt-free with a debt-to-equity ratio of 0.71.
In FY 2023 , Camlin Fine Sciences Ltd recorded a total revenue of approximately 773.26 Cr marking a significant milestone in the company's financial performance.
Camlin Fine Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and 0.1% annually, respectively..
Camlin Fine Sciences Ltd's current PE ratio is -29.08.
Camlin Fine Sciences Ltd's ROCE averaged 5.3% from the FY ending March 2022 to 2024, with a median of 6.6%. It peaked at 9.8% in March 2023, reflecting strong capital efficiency over the period..
Camlin Fine Sciences Ltd's latest EBIT is Rs. -5.30 Cr, surpassing the average EBIT of Rs. 62.59 Cr over the 5 years..